ASCO publishes a suite of peer-reviewed journals with content focused on

  • clinical oncology research;
  • issues and insights affecting oncology practice;
  • cancer care, research, and care delivery issues unique to countries and settings with limited health care resources;
  • biomedical informatics methods and processes applied to cancer-related data, information, and images; and
  • the science and practice of precision oncology.

ASCO’s peer-reviewed journals follow a continuous publication schedule. Below is a select list of the newest content from ASCO’s journals. ASCO will update the list on a near-daily basis, and we encourage you to check this page frequently. Email ASCO’s Media Team to request an embargoed journal article or an interview with a study author. Credentialed media can access published articles on the ASCO Publications site using their ASCO.org login information.

ASCO occasionally highlights select journal articles in an embargoed press release known as a News Digest or in a Featured Article summary. Sign up to receive communications regarding these articles.

Publishing April 30, 2024, 4:00 PM ET:

Identification and Characterization of Immune Checkpoint Inhibitor–Induced Toxicities From Electronic Health Records Using Natural Language Processing (Original Report)
Rajat Mohindra, et al
Request article 

Publishing April 29, 2024, 4:00 PM ET:

Phase Ib Study of Unesbulin (PTC596) Plus Dacarbazine for the Treatment of Locally Recurrent, Unresectable or Metastatic, Relapsed or Refractory Leiomyosarcoma (Original Report)
Esther Brooks-Asplund, et al
Request article

Survivorship Care for People Affected by Advanced or Metastatic Cancer: MASCC-ASCO Standards and Practice Recommendations (Special Article)
Nicolas Hart, et al
Request article

When Is Telemedicine Appropriate in the Management of Head and Neck Cancer? A Mixed-Methods Assessment Among Patients and Physicians (Original Report)
Tony Hung, et al
Request article

Comparison of Comorbidity Models Within a Population-Based Cohort of Older Adults With Non-Hodgkin Lymphoma (Original Report)
Max Gordon, et al
Request article

Publishing April 26, 2024, 4:00 PM ET:

Using Machine Learning to Predict Unplanned Hospital Utilization and Chemotherapy Management From PatientReported Outcome Measures (Original Report)
Zuzanna Wojcik, et al
Request article

Publishing April 25, 2024, 4:00 PM ET:

Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology/GOG Prospective Randomized Multi-Center Clinical Trial (Original Report)
Ann Klopp, et al
Request article

Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update Clinical Insights (Special Article)
ASCO Guidelines, et al
Request article

Exploring the Concordance between High-Risk Human Papillomavirus Infections in Cervical and Oral Sites among Females: A Cross-Sectional Study in Punjab, Pakistan (Original Report)
Sadia Minhas, et al
Request article

Toward Equitable Precision Oncology: Monitoring Racial and Ethnic Inclusion in Genomics and Clinical Trials (Original Report)
Santiago Guerrero, et al
Request article

Characterization of BRAFThr599dup Mutation as a Targetable Driver Mutation Identified in Lung Adenocarcinoma by Comprehensive Genomic Profiling (Original Report)
Yusuke Inoue, et al
Request article

Genomic Correlates of Prostate-Specific Membrane Antigen Expression and Response to 177Lu-PSMA-617: A Retrospective Multicenter Cohort Study (Original Report)
Michael Schweizer, et al
Request article

Melanocortin-1 Receptor Expression as a Marker of Progression in Melanoma (Original Report)
David G. Su, et al
Request article

Published April 24, 2024, 4:00 PM ET:

NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer (Original Report)
Niklas Klümper, et al
Request article

Patient and Caregiver Perceptions of an Interface Design to Communicate Artificial Intelligence–Based Prognosis for Patients With Advanced Solid Tumors (Original Report)
Elizabeth Sloss, et al
Request article 

Published April 23, 2024, 4:00 PM ET:

Trans-Ancestral Genetic Risk Factors for Treatment-Related Type 2 Diabetes Mellitus in Survivors of Childhood Cancer (Original Report)
Yadav Sapkota, et al
Request article

Salvage Reirradiation for Locally Recurrent Prostate Cancer: Results From a Prospective Study With 7.2 Years of Follow-Up (Original Report)
Christian Ekanger, et al
Request article

Datopotamab Deruxtecan in Advanced or Metastatic HR1/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study (Original Report)
Funda Meric-Bernstam, et al
Request article

Published April 22, 2024, 4:00 PM ET:

RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer (Original Report)
Paul Bunn, et al
Request article

Explainable Machine Learning Model to Preoperatively Predict Postoperative Complications in Inpatients With Cancer Undergoing Major Operations (Original Report)
Lily Lai, et al
Request article

Publishing April 19, 2024, 4:00 PM ET:

Laparosopic Versus Open Hemihepatectomy: The ORANGE II PLUS Multicenter Randomized Controlled Trial (Original Report)
Robert Fichtinger, et al
Request article

Published April 18, 2024, 4:00 PM ET:

Clonal Hematopoiesis and Therapy-Related Myeloid Neoplasms After Autologous Transplant for Hodgkin Lymphoma (Original Report)
Smita Bhatia, et al
Request article

Assessing the Role of Inflammation in Oral Tongue Carcinogenesis (Editorial)
Ann Gillenwater, et al
Request article

Methodology for Using Real-World Data From Electronic Health Records to Assess Chemotherapy Administration in Women With Breast Cancer (Original Report)
Elizabeth Kantor, et al
Request article

Uptake of Risk-Reducing Measures, Cascade Testing, and Related Challenges Among Carriers of Breast Cancer-Associated Germline Pathogenic Variants in Mexico (Original Report)
Cynthia Villarreal-Garza, et al
Request article

Randomized Phase II Study of Gemcitabine With or Without ATR Inhibitor Berzosertib in Platinum-Resistant Ovarian Cancer: Final Overall Survival and Biomarker Analyses (Original Report)
Panagiotis Konstantinopoulos, et al
Request article

Transcriptome-Based Prognostic and Predictive Biomarker Analysis of ENACT: A Randomized Controlled Trial of Enzalutamide in Men Undergoing Active Surveillance (Original Report)
Ashley Ross, et al
Request article

Genomic Landscape of Circulating Tumor DNA in Patients With Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor-2–Negative Metastatic Breast Cancer Treated With Abemaciclib: Data From the SCRUM-Japan Cancer Genome Screening Project (Original Report)
Victoria Serelli-Lee, et al
Request article

Prognostic Model for High-Grade Neuroendocrine Carcinoma of the Lung Incorporating Genomic Profiling and Poly (ADP-ribose) Polymerase-1 Expression (Original Report)
Ji-Youn Han, et al
Request article

Tumor Size Is Not Everything: Advancing Radiomics as a Precision Medicine Biomarker in Oncology Drug Development and Clinical Care. A Report of a Multidisciplinary Workshop Coordinated by the RECIST Working Group (Special Article)
Scott Laurie, et al
Request article

Recently published Journal articles are featured on the homepage of each ASCO Journal website. Credentialed media can directly access these articles using their Media HQ login information on the Journal website. You will only need to log in once to access content for all ASCO Journals:

To apply for ASCO media credentials or renew your credentials, visit ASCO’s Media Headquarters and click “Create Account” or log in with your existing account information. To request your username or reset your password, click “Need Help. After submitting the required documentation, you will receive an email notification once your media credentials are approved. Your access to Journal articles will be activated within one week of approval. As you await access, once you have received notification of approved media credentials, submit your requested articles to Journal Request to receive them by email. 

The embargo date and time of a journal article coincide with its online publication date and time. Journalists may conduct embargoed interviews with study authors up to one week prior to the online publication date. ASCO takes embargo violations seriously and violations typically result in the loss of journal media privileges for a period of one year and may affect broader ASCO media privileges as well. Journalists may request embargoed articles. Please direct further questions regarding the embargo policies for ASCO Journals to the Media Team.